Ocrelizumab Reduces Thalamic Volume Loss
Ocrelizumab Reduces Thalamic Volume Loss, – Cenobamate Shines in C017 Study, Trial of LRRK2 Inhibitor BIIB122 Commences Using the phase 3…
Media Update: Patient enrollment of phase III tolebrutinib trials paused in the U.S.
Paris, June 30, 2022. The U.S. Food and Drug Administration (FDA) has placed Phase 3 studies of tolebrutinib in multiple sclerosis (MS)…
Stuart Schlossman
Brain age as a surrogate marker for cognitive performance in multiple sclerosis
Information provided by: Gavin Giovannoni, aka Prof G @GavinGiovannoni Are you ready for some hard-to-process information about the impact of…
Stuart Schlossman
Multiple Sclerosis DMT Waste Is STARTLING, New Study Shows (View the photo with the waste build-up)
June 22, 2022 — by: Alicia Bigica More than $5.2 million in new, unused DMTs were collected from patients with…
Stuart Schlossman
Beer Consumption May Be Linked to MS Risk: Meta-analysis
Alcohol intake is not significantly associated with an increased risk of developing multiple sclerosis (MS), but specifically drinking beer may elevate…
Stuart Schlossman
Research Opportunity for Individuals Diagnosed with Relapsing-Remitting Multiple Sclerosis! – A study to evaluate the effects of three diets
June 2022 Wahls UIHC Clinical Research is recruiting for a new study! You are invited to participate in a research study…
Stuart Schlossman
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers – PubMed
Monica Margoni 1 2, Paolo Preziosa 1 3, Paola Tortorella 4, Massimo Filippi 1 3 5 6 7, Maria A Rocca 8 9 10 Affiliations expand PMID: 35668317 DOI: 10.1007/s13311-022-01252-5 Abstract Multiple sclerosis (MS) is a chronic inflammatory, demyelinating,…
Stuart Schlossman
Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
Published by: Science Advances – April 27, 2022 Abstract Multiple sclerosis (MS) is an inflammatory disease of the central nervous…
Stuart Schlossman
Prevalence of MS Among Black People ‘Under-recognized’: Study
by Lindsey Shapiro PhD | May 5, 2022 Rates of multiple sclerosis (MS) were similar among Black and white people, but significantly lower…
Stuart Schlossman
Four new autoantigens trigger multiple sclerosis
Swiss and Swedish researchers have uncovered four previously unknown autoantigens that trigger multiple sclerosis in mice. April 27, 2022 Article…
Stuart Schlossman
